glutathione s transferase drug resistance

glutathione s transferase drug resistance transferases as mediators of signaling pathways involved in cell proliferation and cell death Unveiling the Role of Glutathione

Name: glutathione s transferase drug resistance transferases as mediators of signaling pathways involved in cell proliferation and cell death Unveiling the Role of Glutathione
Brand: southroadsurgery.com.au
SKU: 85936549222
Price: 25.41 USD
Availability: InStock
Rating: 4.0891 (6 reviews)

Unveiling the Role of Glutathione S transferase Protein in Breast Cancer Drug Resistance: Insights into the Signaling Pathways and Therapeutic Implications ACS Pharmacology & Translational Science glutathione s transferase calcium signaling The Relationship of Glutathione S Transferase and Multi Drug Resistance Related Protein 1 in Nitric Oxide (NO) Transport and Storage Glutathione transferases as mediators of The Multifaceted Role of Glutathione S Transferases in Health and Disease General reaction catalyzed by glutathione S transferases. Download Scientific Diagram The role of glutathione S transferase in anti cancer drug resistance Oncogene Glutathione S transferases P1 mediated interleukin 6 in tumor associated macrophages augments drug resistance in MCF 7 breast cancer ScienceDirect

SKU: 85936549222 · From southroadsurgery.com.au

4.1

USD25.41 USD63.41

Pay in 4 interest-free payments of $6.35 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 16 - Aug 21

Description

A multi-scale target detection method using an improved faster region convolutional neural network based on enhanced backbone and optimized mechanisms

NOX2 creates ROS which drives metastasis by downregulating the functional features of natural killer (NK) cells

In a 26-week rat oral toxicity study, AOD-9604 produced dose-dependent changes in serum osteocalcin (a bone-turnover marker) at week 13, with the direction reversing by week 26

First, accumulating evidence has shown that the expression and function of key efferocytosis receptors, MerTK (183), LRP1 (184), and SR-BI (185) are impaired in advanced atherosclerosis